Despite strong clinical data, RSV immunization rates among pregnant women and older adults remain worryingly low, ...

Vaccines are the best way to protect yourself from those illnesses, as well as from viruses such as RSV, influenza, and COVID-19. Experts say it’s increasingly important to safeguard yourself from all ...

The CDC recently updated RSV vaccine recommendations to include certain adults aged 50 and up. When is the best time to get ...

The NHS in the Black Country is now offering the Respiratory Syncytial Virus (RSV) vaccine at selected local pharmacies, ...

Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in ...

Sanofi acquires Vicebio for $1.15 billion, adding a next-gen RSV-hMPV vaccine and ‘Molecular Clamp' tech to strengthen its ...

Appointments will continue to be issued over the next couple of weeks and pregnant women who are 28-week-plus are also ...

The retrospective cohort study included more than 130,000 people in the US. It reveals that the shingles vaccine (called ...

The acquisition, which will give Sanofi a combination vaccine for respiratory syncytial virus and human metapneumovirus, ...

Sanofi has struck a deal to buy Vicebio for $1.15 billion upfront, securing preclin | Sanofi has struck a deal to buy Vicebio ...

A new UK study shows that vaccinating pregnant women against RSV has led to a staggering 72% drop in hospitalizations of ...

New UK study shows RSV vaccine for pregnant women significantly reduces infant hospital admissions for severe respiratory ...